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In developing countries HIV infection in infancy is a major
problem because of the uncertainties of diagnosis and the
paucity of evidence on outcome following mechanical
ventilation. Acute lower respiratory infection (ALRI) is a
common complication among HIV-infected children,
accounting for 30 - 40% of inpatient admissions and a case
fatality rate of 15 - 28% in southern Africa. 1,2 The diagnosis of
HIV infection in infants is problematic due to transplacental
transmission of maternal HIV-1 antibodies, and the
unavailability of confirmatory HIV DNApolymerase chain
reaction (PCR) tests because of cost constraints. The World
Health Organisation (WHO) proposed a clinical case definition
for paediatric AIDS that is neither sensitive nor specific in
confirming infection.3 The decision to provide mechanical
ventilation for HIV-exposed infants with severe HIV-related
pneumonia is influenced by considerations of ethics, costs and
likely benefits. There is no uniform opinion to assist clinicians
in making such decisions. 
At Ngwelezana and King Edward VIII hospitals in
KwaZulu-Natal, where the public sector antenatal HIV
prevalence rate is 36%, this dilemma is faced weekly.4 We
studied HIV-exposed children (less than 15 months of age)
with severe or very severe pneumonia requiring mechanical
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Object ives.The decision to provide mechanical ventilation
(intermittent positive pressure ventilation (IPPV)) to HIV-
exposed infants in resource-poor settings has remained
difficult owing to problems in confirming HIV infection and
the lack of data on outcome. We evaluated the predictive
value of the HIV antibody test in confirming infection in
infants requiring mechanical ventilation for acute lower
respiratory infections (ALRIs), and compared the outcome for
children denied access with the outcome for similar subjects
who were ventilated. 
Set t ing and design.This investigative study was conducted
over a 12-month period at the paediatric intensive care unit
(PICU) at King Edward VIII Hospital (KEH) in Durban, and
at Ngwelezana Hospital in northern KwaZulu-Natal. 
Subject s.HIV-exposed patients with acute respiratory
failure (ARF) secondary to ALRI entering the PICU at KEH
were enrolled into the IPPV arm, while similar children who
were refused such care at Ngwelezana Hospital were
admitted into the non-IPPV arm. Standardised protocols for
entry and management of enrolled subjects were utilised.
Outcome measures.HIV DNApolymerase chain reaction
(PCR) testing was performed to establish HIV status. Clinical
and laboratory parameters were correlated with HIV status to
determine predictors of infection and outcome (survival to
discharge).
Result s.One hundred and sixteen HIV-exposed infants were
enrolled, 49 into the IPPV arm and 67 into the non-IPPV arm.
The median age of both groups was 3.0 months (0.5 - 11
months), and the male/female ratio and proportion of infants
under 3 months of age were similar in both groups. 
The predictive values of the HIV antibody test in
determining HIV infection in the IPPV and non-IPPV arms
were 87.8% and 85.0 % respectively.  Splenomegaly and a
serum globulin of >35 g/l increased the likelihood of being
HIV PCR- positive (p = 0.006 and p = 0.04 respectively).
Survival to discharge rates for HIV-infected children in the
IPPV and non-IPPV arms were 41.9% and 24.6% respectively
(p = 0.08).  Age less than 3 months (p = 0.04) and very severe
pneumonia (p = 0.007) were the only indicators of poor
outcome. 
Conclusion.Mechanical ventilation provided little benefit in
HIV-infected children with ARF from ALRI.  An HIV
antibody test in infants with ALRI and ARF is highly
suggestive of HIV infection. Splenomegaly and a serum
globulin of greater than 35 g/l were the only useful markers
in identifying HIV infection.
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ventilation to evaluate the usefulness of HIV antibody tests in
predicting infection. We also compared the outcome of children
receiving intermittent positive-pressure ventilation (IPPV) with
that of similar children who were denied such care.
Patients and methods
An investigative study (June 1999 - May 2000) was conducted
at the paediatric intensive care unit (PICU) at King Edward
VIII Hospital (KEH) and the paediatric wards at Ngwelezana
Hospital in KwaZulu-Natal, South Africa. The PICU at KEH is
the only public sector intensive care service available to a
paediatric population of 3 - 4 million. Approximately 400
children are admitted annually, with an overall mortality rate
of 25%.5 The unit has a bed capacity of 10 and an occupancy
rate of over 90%.  The unit is staffed by 2 consultants and 4
registrars/medical officers.  The nurse-to-patient ratio is 1:3.
Criteria for entry into the unit included the need for airway
support, and invasive and non-invasive monitoring. 
Ngwelezana Hospital is a subregional facility serving a rural
and peri-urban population of 2 million. There are 140
paediatric beds, including 9 for high care. Forty-five per cent of
the 13 daily paediatric admissions are for ALRI, while 75% of
those tested for HIV are positive. A consultant and 7 medical
officers make up the staff complement. The nurse-to-patient
ratio in the paediatric high care unit is 1:5. HIV antibody tests
(enzyme-linked immunosorbent assay (ELISA) or the Rapid
Stat test) are usually available but results for HIV DNAPCR
confirmatory tests take 2 weeks. Transportation of babies to the
PICU at KEH takes on average 6 - 12 hours after acceptance. 
HIV-exposed children less than 15 months of age with ALRI
were recruited if they fulfilled one or more of the following
criteria: oxygen saturation <  89% on 2 l of nasopharyngeal
oxygen or 8 l of headbox oxygen, type 1 or type 2 respiratory
failure on 2 l of nasopharyngeal oxygen; prolonged apnoea,
and persistent metabolic acidosis (p H < 7.25) after 8 hours of
fluid resuscitation. Children who received sustained IPPV were
included in the ventilated arm while those denied ventilation
due to lack of facilities were included in the non- ventilated
arm. Babies who failed to thrive, those with WHO- defined
paediatric AIDS, and previous HIV-related PICU admissions
were not admitted to the PICU. At Ngwelezana, patients were
cared for in high care or in a general ward. 
Identical admission laboratory tests, viz. a full blood count,
electrolytes, liver function tests, HIV ELISA or Rapid Stat test,
HIV DNAPCR, blood gases and radiology, were performed in
both groups. HIV antibody-positive children were regarded as
HIV-exposed, while HIV DNAPCR-positive children were
regarded as HIV-infected.  Antimicrobial therapy was
prescribed according to WHO guidelines for severe and very
severe pneumonia. High-dose intravenous cotrimoxazole and
corticosteroids were used for cases of Pneumocyst is carinii.
Failure to respond to these medications within 72 hours
resulted in an empirical change to cefotaxime and amikacin at
both institutions unless microbiological culture results
indicated otherwise. The need for oxygen therapy,
physiotherapy, blood transfusions and fluid and feeding
practices were standardised for both sites before
commencement of the study. An in-house nested HIV DNA
PCR that targets a conserved region of the HIV gag gene was
used to detect the presence of HIV proviral DNA. The
amplification of a visible 160 base pair product in ethidium
bromide-stained agarose gels was regarded as positive for HIV
infection. 
A leaflet in the native language of participants explaining the
need for the HIV test was given to all possible subjects before
enrolment. Informed consent for HIV testing was granted in all
cases. HIV testing was performed with pre- and post-test
counselling and parents were offered the option of being
blinded to these results. Where facilities for intensive care were
not available, parents/guardians were informed accordingly.
The study protocol received ethical approval from the
University of Natal and the Medical Superintendent of
Ngwelezana Hospital.
The principal dependent variable for analysis was outcome
defined as ‘survival to discharge’.  Capture and analysis of data
were carried out using EPI-Info version 6.04 (Centers for
Disease Control, Atlanta). Analysis of anthropometric data,
lymphocyte count and serum protein gap required
stratification of the sample.  The median value was used as the
cut-off point.  p-values are reported.
Results
One hundred and sixteen children were enrolled during the
study period, 67 in the non-ventilated arm at Ngwelezana and
49 in the ventilated arm at KEH.  Ten patients at Ngwelezana
Hospital who presented in extremis and who were supported
suboptimally on a transport ventilator were included into the
non-ventilated arm for the analysis of outcome. The median
age of both groups was 3.0 months (range 0.5 - 11 months). The
male/female ratio was 1:1.63 and 1:1.04 for Ngwelezana and
KEH respectively. The differences in the clinical characteristics
between the two groups are shown in Table I.
Of the 116 children recruited, 100 (86.2%) were PCR-positive,
being similarly represented in the Ngwelezana and KEH
cohorts (85.0% and 87.8% respectively) (Table II). The presence
of splenomegaly (p = 0.006) and a serum globulin level of 
> 35 g/l (p = 0.04) were associated with an increased likelihood
of being HIV DNAPCR-positive. No association could be
found between the HIV-exposed and infected children for age
less than or greater than 3 months (p = 0.75), sex (p = 0.34),
nutritional status (mean z-score less than or greater than 3, 
p = 0.21), hepatomegaly (p = 0.24), lymphadenopathy (p = 0.2),
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previous hospitalisations (p = 0.28), lymphocyte counts 
(p = 0.93) or WHO-defined paediatric AIDS (p = 0.27).
There was no statistically significant difference between the
survival to discharge of HIV DNAPCR-positive children who
received IPPV and that of children who did not receive IPPV
(41.9% v. 24.6%, p = 0.08) (Table II). The survival to discharge
for cases with negative HIV DNAPCR results were similar for
those receiving IPPV and those not ventilated (66.7% v. 60%,
p = 0.20). Overall, the survival to discharge of HIV DNAPCR-
negative children was higher than that for HIV DNAPCR-
positive children (63% v. 32%, p = 0.02).
At both sites, age less than 3 months compared with age
above 3 months  (OR 2.3, p = 0.04) and WHO-defined very
severe pneumonia (OR 3.37, p = 0.007) were predictive of poor
outcome. Failure to thrive (p = 1.00), previous hospital
admissions (p = 0.84), hepatomegaly (p = 0.86), splenomegaly
(p = 0.74), lymphadenopathy (p = 0.04), WHO-defined clinical
AIDS (p = 0.86), a high serum globulin level (p = 0.23) and a
low total lymphocyte count (p = 0.2) were of no prognostic
value in determining outcome. 
The median lengths of stay for all patients and survivors at
KEH were 10 (range 1 - 50) and 9 (range 1 - 50) days
respectively. At Ngwelezana the median lengths of stay for all
patients and survivors were 4 (range 0 - 34) and 9 (range 3 - 20)
days respectively. The median duration of IPPV and ICU stays
were 9 and 16 days respectively.
P. cariniipneumonia (PCP) (N = 16), mixed infections (PCP,
Candida, cytomegalovirus and bacteria N = 9), nosocomial
Gram-negative bacteria (Acinetobacter anit ratusand
Klebsiella pneumoniae N = 8), and community-acquired
bacterial pneumonia (St aphylococcus aureusand
St rept ococcus pneumoniae N= 7) were the common
pathogens identified in the HIV DNAPCR-positive cohort
receiving intensive care. Bordet ella pert ussis(N = 2), S.
aureus(N = 2), Moraxella cat arrhalis(N = 1) and tuberculosis
(N = 1) were the pathogens identified in the HIV  DNAPCR-
negative children who were ventilated. PCP (44%), mixed
infections (36%) and nosocomial pneumonias (16%) were
responsible for the majority of deaths in this cohort. The
aetiology of the pneumonia for children managed at
Ngwelezana was not determined. 
Discussion
Rational allocation of limited intensive care facilities can only
be accomplished with adequate knowledge of outcome of
conditions requiring such care. Ethical concerns do not allow
medical emergencies to be evaluated using double-blind
randomised control studies, but where such cases are
continually being denied optimal care due to the lack of
facilities, investigational studies are deemed clinically justified.
The most important finding of this study, the first in the world,
is the lack of benefit of mechanical ventilation in HIV-infected
children under 15 months of age with ALRI and ARF
compared with similar children who were refused ventilatory
support. This was especially so in infants under 3 months of
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Table I. Differences in the clinical characteristics of cases receiving and not receiving mechanical ventilation
HIV-exposed, HIV-exposed, 
Variables no IPPV (N = 67) IPPV (N = 49) p-value
Z-score (3 SD) -1.86 (1.23) -0.78 (1.41) 0.003
Lymphadenopathy (N (%))
Yes 17 (25.4) 23 (46.9) 0.05
No 50 (74.6) 26 (53.1) NS
Paediatric AIDS(WHO) (N (%))
Yes 27 (40.3) 3 (6.1) < 0.01
No 40 (59.7) 46 (93.9) < 0.001
Severity of pneumonia (N (%))
Severe 43 (64.2) 17 (34.7) 0.001
Very severe 24 (35.8) 32 (65.3) 0.001
IPPV = intermittent positive pressure ventilation; SD = standard deviations.
Table II. HIV infectivity and survival among HIV antibody-
positive children receiving and not receiving mechanical
ventilation (N (%))
HIV antibody- HIV antibody
Variables positive, no IPPV positive, IPPV      
HIV DNAPCR-positive 57/67 (85.0) 43/49 (87.8)
HIV DNAPCR-negative 10/67 (14.9) 6/49 (12.2)
Survival 
HIV DNAPCR-positive 14/57 (24.6) 18/43 (41.9)
HIV DNAPCR-negative 6/10 (60)        4/6 (66.7)   
IPPV = intermittent positive pressure ventilation.   
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age and those with WHO-defined very severe pneumonia.
HIV-exposed but uninfected children with similar severity of
illness have better outcomes than HIV-infected children.
Should HIV antibody-positive children be offered intensive
care? In the USA, children with HIV-related acute respiratory
failure requiring IPPV have ICU survival rates of 50 - 81%.6,7
PCP was the commonest cause of ICU admission and had the
worst outcomes.8 The introduction of corticosteroids to the
management of these children improved the short-term
outcome, but long-term survival at 30 months remains the
same at 0 - 60%. 9,10
Poor prognostic factors have been identified in these studies.
CD4 counts < 50 cells/µl, lactate dehydrogenase (LDH) levels
> 1 000 IU, serum albumin < 20 g/dl, serum creatinine 
> 24 µg/dl, a diagnosis of AIDS of less than 1 year’s duration,
persistent hypoxaemia and pneumothoraces have been
associated with worse outcome,11 but have not been tested in
developing countries.  
A second important finding of this study was the high
predictive value of the HIV antibody test for this population.
The overall figure of 86.2% PCR positivity should be viewed in
the context of the disease studied and the high HIV prevalence
for the region. An estimated 12% of the general population
served by these hospitals are HIV-infected.4 It is useful for
doctors working in these and similar regions to assume that a
positive HIV antibody result in babies under 15 months
requiring ventilation for pneumonia is suggestive of true HIV
infection.  Only splenomegaly and serum globulin > 35 g/l
were useful in predicting HIV infection, although these
features need verification. 
The use of the PCR to detect HIV-proviral DNAand the
reverse transcriptase PCR to detect free virus have been widely
used to identify HIV-infected infants reliably at all ages after
birth.  The commercial assays, while sensitive and specific, are
costly and not readily available. The HIV DNAPCR assay
utilised in this study has undergone prior evaluation and
achieved sensitivities and specificities equal to the commercial
kits, but is more affordable (D F York — personal
communication).
There are several limitations to the utilisation of these
findings. Although great effort was taken to ensure that the
two groups would be comparable, the difference in the nurse/
patient ratios between the two groups, the lack of
microbiological evaluations in the Ngwelezana cohort, the
delay in transportation of cases to the PICU after acceptance,
and the different locations where patients were nursed may
have  influenced the outcome significantly. No case received
antiretroviral therapy and therefore these findings would only
be applicable in HIV treatment-naïve populations.  
In this limited study, conventional mechanical ventilation
does not offer substantial gains over non-ventilatory care for
HIV-infected children under 15 months of age with ALRI and
ARF. HIV-exposed but uninfected children with similar illness
fare better than HIV-infected children. Children with very
severe pneumonia or those less than 3 months of age have the
worst outcome. A positive HIV antibody test in children with
ALRI and ARF has an 86.2% predictive value of true HIV
infection. Only splenomegaly and a serum globulin of greater
than 35 g/l are predictive of true HIV infection.             
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